|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Fairmount Funds Management LLC
✚
|
|
|---|---|
| CRD # | 284844 |
| SEC # | 801-116848 |
| CIK # | 0001802528 |
| AUM | $3.2 B (2025-03-31) |
| Employees | 31 (45% Investors, 0% Brokers) |
| Phone | 267-262-5300 |
| Address | 200 Barr Harbor Drive West Conshohocken, PA 19428 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001802528 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Apogee Therapeutics Inc | 89.0 | ||
| Axsome Therapeutics Inc | 85.1 | ||
| Imara Inc | 74.5 | ||
| Scholar Rock Holding Corp | 64.6 | ||
| Aeglea Biotherapeutics Inc | 60.2 | ||
| Nuvalent Inc | 55.5 | ||
| Magenta Therapeutics Inc | 50.4 | ||
| Kiniksa Pharmaceuticals Ltd | 49.1 | ||
| Signal Genetics Inc | 48.4 | ||
| UNUM Therapeutics Inc | 44.7 | ||
| ARCA Biopharma Inc | 37.8 | ||
| Aerovate Therapeutics Inc | 32.2 | ||
| Glycomimetics Inc | 22.4 | ||
| Catabasis Pharmaceuticals Inc | 19.1 | ||
| Zenas Biopharma Inc | 18.3 | ||
| Inhibikase Therapeutics Inc | 11.9 | ||
| CytomX Therapeutics Inc | 8.8 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Fairmount Healthcare Co-Invest IV LP | [2025-02-20] | 0.0 | 25.3 |
| PE | Fairmount Healthcare Co-Invest III LP | [2024-08-15] | 0.0 | 50.5 |
| PE | Fairmount Healthcare Co-Invest II LP | [2023-11-15] | 15.2 | 24.9 |
| PE | Fairmount Healthcare Co-Invest LP | [2023-08-18] | 25.0 | 38.7 |
| PE | Fairmount SPV I LLC | 2022-03-31 | 1.6 | |
| PE | Fairmount SPV III LLC | 2020-04-17 | 0.6 | |
| HF | Fairmount Healthcare Fund II LP | [2019-05-24] | 28.0 | 3,093.0 |
| PE | Fairmount SPV II LLC | 2019-05-24 | 0.4 | |
| HF | Fairmount Healthcare Fund LP | [2018-02-13] | 28.0 | 111.0 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 3.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 3.2 |
| By Discretionary | ||
| Discretionary | 3 | 3.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 3.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.5 | |
| United States Persons | 1.7 | |
| Total | 3 | 3.2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001802528] | |
| 3 | [0001802528] | |
| 4 | [0001802528] | |
| SC 13D | [0001802528] | |
| SC 13G | [0001802528] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
VR Adviser LLC
✚
|
NY | 3.3 |
|
KA Fund Advisors LLC
✚
|
TX | 3.3 |
|
LGK Advisors LLC
✚
|
NY | 3.2 |
|
Luminarx Capital Management LP
✚
|
NY | 3.2 |
|
Pretium Credit Management LLC
✚
|
NY | 3.2 |
|
Foresite Capital Management LLC
✚
|
CA | 3.2 |
|
First Sentier Investors Australia Infrastructure Managers PTY
✚
|
3.2 | |
|
Axar Capital Management LP
✚
|
NY | 3.1 |
|
Electric Capital Partners LLC
✚
|
CA | 3.1 |
|
RGM Capital LLC
✚
|
FL | 3.1 |